A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sponsor: Sanofi
Kansas City, MO · +33 more sites
10 recruiting type 1 diabetes studies with a site in Kansas City, MO.
Sponsor: Sanofi
Kansas City, MO · +33 more sites
Sponsor: SAb Biotherapeutics, Inc.
Kansas City, MO · +21 more sites
Sponsor: AstraZeneca
Kansas City, MO · +22 more sites
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Kansas City, MO · +11 more sites
Sponsor: COUR Pharmaceutical Development Company, Inc.
Kansas City, MO · St Louis, MO · +43 more sites
Sponsor: Nemours Children's Clinic
Kansas City, MO · +1 more sites
Sponsor: Novo Nordisk A/S
Kansas City, MO · St Louis, MO · +107 more sites
Sponsor: AstraZeneca
Jefferson City, MO · Kansas City, MO · +31 more sites
Sponsor: Sanofi
Kansas City, MO · +36 more sites
Sponsor: University of South Florida
Kansas City, MO · +16 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.